Scroll To Top
News

Cancer Watch

Cancer Watch

Magnify_0

There's good news and bad news for HIVers when it comes to non-Hodgkin's lymphoma, one of three AIDS-defining cancers. The upside is that successful antiretroviral therapy slashes risks for the disease by half. But the bad news, according to a study of nearly 8,500 people who developed the cancer, is that HIVers -- even those successfully treated with antiretroviral drugs -- are twice as likely to die within two years of their lymphoma diagnosis than are HIV-negative adults.

From our Sponsors

Most Popular

Latest Stories

HIV Plus Editors

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.